Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07505810 Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences) Meningitis, Meningococcal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07505810 clinical trial report covering Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences), Phase 3, endpoints, sponsor, geography, r
Latest Hotspot
8 min read
ChiCTR2600121588 Methylprednisolone sodium succinate Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
ChiCTR2600121588 clinical trial report covering Methylprednisolone sodium succinate, Phase 3, endpoints, sponsor, geography, readout timing and development
Latest Hotspot
8 min read
NCT07506512 Misoprostol Abortion Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07506512 clinical trial report covering Misoprostol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07509099 Cetuximab Squamous Cell Carcinoma of Head and Neck Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07509099 clinical trial report covering Cetuximab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261262 Copper (64Cu) Oxodotreotide Somatostatin Receptor-Positive Neuroendocrine Tumor Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20261262 clinical trial report covering Copper (64Cu) Oxodotreotide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261195 Gadopiclenol Vascular Malformations Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20261195 clinical trial report covering Gadopiclenol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600121751 Albumin-Bound Paclitaxel Uterine Cervical Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
ChiCTR2600121751 clinical trial report covering Albumin-Bound Paclitaxel, Phase 3, endpoints, sponsor, geography, readout timing and development white spac
Latest Hotspot
8 min read
NCT07506863 Mitapivat Transfusion-dependent Thalassemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07506863 clinical trial report covering Mitapivat, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CHRNA10 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-10 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRNA10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CHRNA3 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRNA3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CHRNA2 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRNA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CHRNA1 Biologics Sequence Review Report 2026: Acetylcholine receptor subunit alpha Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CHRNA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.